China investigating product name issues:
This article was originally published in Clinica
Executive Summary
Glucose test strips and condoms are among the medical devices whose "product classification and terminology" are under investigation in China. Problems are arising currently because manufacturers sometimes use a different name for the same product or family of products. This is causing misunderstandings among management bodies and users, Dr Zhixiu Yao of the China Association for Medical Devices Industry (CAMDI), told Clinica. The issue is described by Dr Yao as "an unsolved headache for the State Food and Drug Administration (SFDA)". The matter has been under SFDA investigation since April 3.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.